Abstract:As corona virus disease 2019 (COVID-19) is a rapidly growing public health crisis across the world, our knowledge of meaningful diagnostic tests and treatment for severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) is still evolving. This novel coronavirus disease COVID-19 can be diagnosed using RT-PCR, but inadequate access to reagents, equipment, and a nonspecific target has slowed disease detection and management. Precision medicine, individualized patient care, requires suitable diagnostics approaches to tackle the challenging aspects of viral outbreaks where many tests are needed in a rapid and deployable approach. Mass spectrometry (MS)-based technologies such as proteomics, glycomics, lipidomics, and metabolomics have been applied in disease outbreaks for identification of infectious disease agents such as virus and bacteria and the molecular phenomena associated with pathogenesis. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF/MS) is widely used in clinical diagnostics in the United States and Europe for bacterial pathogen identification. Paper spray ionization mass spectrometry (PSI-MS), a rapid ambient MS technique, has recently open a new opportunity for future clinical investigation to diagnose pathogens. Ultra-high-pressure liquid chromatography coupled high-resolution mass spectrometry (UHPLC-HRMS)-based metabolomics and lipidomics have been employed in large-scale biomedical research to discriminate infectious pathogens and uncover biomarkers associated with pathogenesis. PCR-MS has emerged as a new technology with the capability to directly identify known pathogens from the clinical specimens and the potential to identify genetic evidence of undiscovered pathogens. Moreover, miniaturized MS offers possible applications with relatively fast, highly sensitive, and potentially portable ways to analyze for viral compounds. However, beneficial aspects of these rapidly growing MS technologies in pandemics like COVID-19 outbreaks has been limited. Hence, this perspective gives a brief of the existing knowledge, current challenges, and opportunities for MS-based techniques as a promising avenue in studying emerging pathogen outbreaks such as COVID-19.

Identification of Pathogens by Mass Spectrometry

Current status of MALDI-TOF mass spectrometry in clinical microbiology

Simultaneous Detection of Key Bacterial Pathogens Related to Pneumonia and Meningitis Using Multiplex PCR Coupled with Mass Spectrometry.

Application and use of various mass spectrometry methods in clinical microbiology

Introduction of Mass Spectrometry-based Microorganism Detection

MALDI-TOF MS for Pathogenic Bacteria Analysis

Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS) Analysis for the Identification of Pathogenic Microorganisms: A Review

Multidimensional mass profiles increase confidence in bacterial identification when using low-resolution mass spectrometers

Microorganism Identification by Mass Spectrometry and Protein Database Searches

Rapid and robust MALDI-TOF MS techniques for microbial identification: a brief overview of their diverse applications

[Mass spectrometry in the clinical microbiology laboratory]

The Current Level of MALDI-TOF MS Applications in the Detection of Microorganisms: A Short Review of Benefits and Limitations

Identification of Microorganisms by High Resolution Tandem Mass Spectrometry with Accurate Statistical Significance

Present and Future Perspectives on Mass Spectrometry for Clinical Microbiology

Mass spectrometry-based proteomic approaches to study pathogenic bacteria-host interactions

Recent Advances and Ongoing Challenges in the Diagnosis of Microbial Infections by MALDI-TOF Mass Spectrometry

High-Throughput Metagenomics for Identification of Pathogens in the Clinical Settings

Mass Spectrometry in Crop Pathogens Diagnosis: A Comprehensive Review

Application of Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry for Identification of Foodborne Pathogens: Current Developments and Future Trends.

Mass Spectrometry Techniques in Emerging Pathogens Studies: COVID-19 Perspectives

Mass Spectrometry Analysis for Clinical Applications: A Review.